Literature DB >> 4126572

Cost of preventing retrolental fibroplasia?

K W Cross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4126572     DOI: 10.1016/s0140-6736(73)92610-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  38 in total

1.  High or low oxygen saturation for the preterm baby.

Authors:  N McIntosh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

2.  Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight.

Authors:  J Vyas; D Field; E S Draper; G Woodruff; A R Fielder; J Thompson; N J Shaw; D Clark; R Gregson; J Burke; G Durbin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

3.  Management of hyaline membrane disease.

Authors:  N R Roberton
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

4.  ROP and neurodevelopmental disabilities.

Authors:  G E Quinn
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

5.  Neonatal mortality since 1935.

Authors:  S Sepkowitz
Journal:  BMJ       Date:  1992-03-21

6.  Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels.

Authors:  David K Wallace; Kathleen A Veness-Meehan; William C Miller
Journal:  J AAPOS       Date:  2006-11-09       Impact factor: 1.220

7.  A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.

Authors:  Kenneth W Wright; David Sami; Lisa Thompson; Rangasamy Ramanathan; Roy Joseph; Sonal Farzavandi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  First day neonatal mortality since 1935: re-examination of the Cross hypothesis.

Authors:  R K Whyte
Journal:  BMJ       Date:  1992-02-08

9.  Causes of severe visual impairment in children and their prevention.

Authors: 
Journal:  Doc Ophthalmol       Date:  1975-12-30       Impact factor: 2.379

10.  Algorithms that eliminate the effects of calibration artefact and trial-imposed offsets of Masimo oximeter in BOOST-NZ trial.

Authors:  Marina Zahari; Dominic Savio Lee; Brian Alexander Darlow
Journal:  J Clin Monit Comput       Date:  2015-08-18       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.